Skip to content

Company information lookup

BENITEC BIOPHARMA LIMITED (BLT)

Biotechnology, research and development.

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
BLT 1.045 0% 1.030 1.045 1.095 1.095 1.025 105,492

BENITEC BIOPHARMA LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code BLT
Securities
Official Listing Date 17 February, 1997
GICS Industry Group Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign? No
Internet Address http://www.benitec.com
Registered Office Address Level 16, 356 Collins Street, MELBOURNE, VIC, AUSTRALIA, 3000
Head Office Telephone (02) 9555 6986
Head Office Fax (03) 8678 1342
Share Registry COMPUTERSHARE INVESTOR SERVICES PTY LIMITED
YARRA FALLS, 452 JOHNSTON STREET, ABBOTSFORD, VIC, AUSTRALIA, 3067
Share Registry Telephone 1300 787 272
Directors / Senior Management
Mr Peter Francis (Non Exec. Chairman)
Dr Peter French (Managing Director, CEO)
Mr Kevin Buchi (Non Exec. Director)
Dr John Chiplin (Non Exec. Director)
Mr Iain Ross (Non Exec. Director)
Company Secretary Mr Greg West
Principal Activities Biotechnology, research and development.

BENITEC BIOPHARMA LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
21/07/2014 asterix HCV TRIAL UPDATE 2 PDF
18/07/2014   BIOSHARES CLINICAL TRIALS PRESENTATION 1 PDF
11/07/2014   ATTACHMENT TO GUIDANCE ON TRIALS ANNOUNCEMENT 2 PDF
11/07/2014 asterix GUIDANCE ON CLINICAL TRIAL UPDATES 2 PDF
01/07/2014   UNMARKEATBLE PARCELS 6 PDF
26/06/2014 asterix CALIMMUNE TRIAL ADVANCES 2 PDF
24/06/2014   Change in substantial holding 2 PDF
20/06/2014   Final Director's Interest Notice 2 PDF
19/06/2014   DIRECTOR RESIGNATION 1 PDF
11/06/2014   NON DEAL ROADSHOW PRESENTATION 15 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
29 Jul 2014 1.045 1.46% 1.095 1.025 105,492
28 Jul 2014 1.030 -4.63% 1.100 1.027 374,935
25 Jul 2014 1.080 -4.42% 1.125 1.070 116,915
24 Jul 2014 1.130 0.89% 1.150 1.110 105,204
23 Jul 2014 1.120 0.9% 1.160 1.110 90,527

* Volume of shares shown represents only those shares traded on ASX.

BENITEC BIOPHARMA LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security BLT. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security BLT

Warrants & Structured Products

No warrants & Structured Products are available over the security BLT

ASX CFDs

No Contracts For Differences are available over the security BLT